Endotronix raised $3 million and is looking to bring in another $540,000 in a new round of debt financing, according to an SEC filing posted last week.
Woodridge, Ill.-based Endotronix develops wireless cardiac monitors, including a ‘tiny pressure sensor’ designed to be implanted in a patient’s pulmonary artery during a catheterization procedure, to wirelessly return PA pressure to portable reader device, according to the company’s website.
Data from the device can be transmitted to healthcare providers through a wireless link to Endotronix software, and is stored and analyzed by the company’s system.
The money from the round comes from 25 unnamed investors, and Endotronix has not yet said what it plans to do with the funds raised from the round, according to the SEC filing.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.